Study of Combivir for Patients With Primary Biliary Cirrhosis

NCT00490620 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Primary Biliary Cirrhosis

Interventions

DRUG: Combination antiviral therapy
DRUG: Placebo

Sponsor

University of Alberta

Collaborators

[object Object]
[object Object]